Bioterrorism is the intentional release of viruses, bacteria, fungi, or biological toxins to cause disease or death among people, livestock, or food crops. The goal is to terrorize a civilian population or pressure a government. Unlike conventional attacks, a bioterrorism event may not be immediately obvious: the agents involved are often invisible, odorless, and tasteless, and symptoms in victims can take days to appear.
How Bioterrorism Differs From Natural Outbreaks
The earliest signs of a bioterrorism attack often look like a bad flu season. Many biological agents cause nonspecific early symptoms like fever, fatigue, and body aches, making them difficult to distinguish from routine illness. What raises suspicion is the pattern. A single confirmed case of smallpox anywhere in the world, a case of inhalational anthrax with no occupational explanation, or a case of viral hemorrhagic fever in someone who hasn’t traveled internationally would all trigger an immediate investigation.
Clusters matter too. Multiple cases of pneumonic plague or pneumonic tularemia appearing in a short window within a small geographic area, or an unexplained spike in serious illness and death, are treated as potential indicators of deliberate release. Detection depends heavily on alert clinicians recognizing something unusual and on surveillance systems designed to catch abnormal patterns in emergency room visits and hospital admissions before a formal diagnosis is even made.
Categories of Biological Threat Agents
The CDC classifies potential bioweapons into three priority tiers based on how dangerous they are and how easily they could be used in an attack.
- Category A (highest priority): Agents that are easy to spread, cause high death rates, trigger public panic, and demand special public health preparation. Anthrax, smallpox, and plague fall here.
- Category B: Agents that are moderately easy to spread and cause moderate illness rates. These require stronger disease monitoring but are considered less likely to cause mass casualties.
- Category C: Emerging pathogens that could potentially be engineered for wide release in the future. They don’t pose an immediate mass-casualty risk but have the potential for high impact if weaponized.
Anthrax sits at the top of the threat list for practical reasons. The bacteria occur naturally, can be produced in a lab, and form spores that survive for years in soil or on surfaces. Those spores can be ground into powders, mixed into sprays, or slipped into food and water. Inhaled anthrax, the most dangerous form, is classified as a Tier 1 biological select agent because it can be fatal without immediate treatment.
Notable Attacks in History
The largest bioterrorism attack on U.S. soil happened in 1984 in The Dalles, Oregon, a small city of about 10,500 people. Members of the Rajneeshee cult contaminated salad bars, coffee creamer, and salad dressing at 10 restaurants with Salmonella bacteria. Their goal was to sicken enough local voters to swing an upcoming county election in favor of their candidates. The attack made 751 people severely ill with gastrointestinal poisoning. Cult members had also sprinkled Salmonella over produce at a local grocery store. The plot wasn’t uncovered for over a year.
The 2001 anthrax letter attacks are the other landmark case. Letters containing powdered anthrax spores were mailed to news organizations and U.S. Senate offices, causing 22 infections: 11 inhalational and 11 cutaneous (skin) cases. Twelve of the victims were mail handlers. All five deaths occurred among those who inhaled the spores, a case-fatality rate of 45% for inhalational anthrax. Molecular testing confirmed that every sample, from the envelopes, patient specimens, and environmental swabs, contained the same indistinguishable strain.
How Governments Prepare and Respond
The international legal framework rests on the Biological Weapons Convention, which prohibits member states from developing, producing, stockpiling, or retaining biological agents or toxins in quantities that have no peaceful justification. It also bars countries from building delivery systems for such agents and from helping any other entity acquire them. Nations that sign the treaty are required to destroy existing stockpiles or redirect them to peaceful research.
On the detection side, the United States operates BioWatch, a network of air samplers running continuously in more than 30 major metropolitan areas. The devices pull air through dry filters that collect airborne particles. Every 24 hours (or more frequently during high-profile events like political conventions), the filters are collected and sent to labs for genomic analysis to check for DNA from specific threat pathogens. The system was adapted from technology originally developed at Los Alamos National Laboratory.
For treatment, the U.S. maintains the Strategic National Stockpile, a federal reserve of antibiotics, antitoxins, antidotes, intravenous fluids, personal protective equipment, and surgical supplies positioned to deploy quickly when local supplies run out. The stockpile is designed for any mass health emergency but includes countermeasures specifically chosen for biological threats.
Why the Threat Landscape Is Shifting
The cost and expertise needed to manipulate biological agents have dropped significantly. Gene editing and gene synthesis tools that were once confined to well-funded research labs are now widely accessible, and the techniques keep getting cheaper and more reproducible. A 2018 report from the National Academies concluded that the most immediate risks involve making small, targeted changes to known pathogen genomes to increase how deadly or contagious an organism is, or to streamline the production of dangerous substances.
Artificial intelligence has added another layer. AI tools can accelerate the spread of technical knowledge related to biology and biosecurity while also enhancing the ability to design novel threats from scratch. As synthetic biology advances, the possibility of engineering something that combines the devastating impact of a natural pathogen with the difficulty of tracing a manufactured toxin becomes more realistic. Current screening methods focus on recognizing known pathogen sequences, but threats built from entirely new proteins or disguised genetic code could potentially evade those systems.